The Decline in Walking Performance in Adults With Cerebral Palsy - Influence of Performance Fatigability
Key facts
- Who runs it
- Centre Hospitalier Universitaire de Saint Etienne
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 30 people enrolled
- Started
- 2 May 2023
- Ended
- 10 Jul 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Fatigability assessment
- Record updated
- 26 October 2024
- Why it stopped
- Lack of inclusion
Who can take part
- Age
- 18 years to 50 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Common for CP and healthy volunteers:
- Capable of walking for six minutes without stopping
- Capable of consenting to the tests; Specific for the CP group
- GMFCS I or II at age 18
- Spastic diplegic cerebral palsy
Who cannot take part
- Accompanying diseases not allowing for the test setup
- Counter-indications to the test procedures
- Mental retardation or intelligence quotient (IQ) below 80
- Major surgeries altering performance in the last six months
- Injection of botulin altering maximal force production in the last three months
- Refusing to sign the consent form
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Due to an early brain injury occurring in antenatal or postnatal, cerebral palsy (CP) causes alteration in motor function with posture and gait disorders. It is commonly observed motor performance degradation during adulthood, and the underlying pathophysiology remains poorly known.
The 2 groups in the trial
- Patients with cerebral palsyTreatment being tested
A specially adapted recumbent cycle ergometer with the ability to quickly transform into an isometric dynamometer will be used to assess fatigability development during a task to failure. Throughout the task, which consists of blocks of 3 minutes, neuromuscular assessments will take place to determine the evolution of fatigability and its peripheral and central determinants.
Treatment: Fatigability assessment
- Healthy peopleExisting treatment, for comparison
A specially adapted recumbent cycle ergometer with the ability to quickly transform into an isometric dynamometer will be used to assess fatigability development during a task to failure. Throughout the task, which consists of blocks of 3 minutes, neuromuscular assessments will take place to determine the evolution of fatigability and its peripheral and central determinants.
Treatment: Fatigability assessment
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Record updated
- 26 October 2024